Anatomic Stage IIIA Breast Cancer AJCC v8 Recruiting Phase 3 Trials for Tucatinib (DB11652)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04457596T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialTreatment